IHH Appeals Tokyo Court Dismissal of Daiichi Claim

Malaysia's IHH Healthcare has appealed a Tokyo court decision dismissing its damages claim against Daiichi Sankyo regarding an Indian stake acquisition. The subsidiary sought up to 1.14 billion dollars for losses tied to approval delays. IHH also plans to expand its stake in Fortis.

Xurve View
Insights:
FILE PHOTO: A signage of IHH Healthcare at their corporate office in Singapore, January 16, 2026. REUTERS/ Yantoultra Ngui/File Photo

IHH HEALTHCARE BHD appealed a Japan court's dismissal of a 109.3 billion Indian rupee ($1.14B) damages claim against DAIICHI SANKYO CO LTD on Thursday afternoon. The legal challenge stems from acquisition delays involving FORTIS HEALTHCARE LTD in India after a dispute between third parties. The dispute blocked the Malaysia-based healthcare group from completing an open offer for an additional stake in Fortis.